zł
1.78
Jul 4
Business Description
Inno-Gene SA
NAICS : 622110
SIC : 8062
ISIN : PLINNGN00015
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.78 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.36 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.65 | |||||
Beneish M-Score | 9.05 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 136.1 | |||||
3-Year EBITDA Growth Rate | 15.8 | |||||
3-Year FCF Growth Rate | -30.7 | |||||
3-Year Book Growth Rate | 52.4 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.06 | |||||
9-Day RSI | 50.77 | |||||
14-Day RSI | 48.33 | |||||
6-1 Month Momentum % | -21.93 | |||||
12-1 Month Momentum % | -64.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.21 | |||||
Quick Ratio | 2.2 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 17821.13 | |||||
Days Sales Outstanding | 669.09 | |||||
Days Payable | 6360.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.54 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 97.59 | |||||
Operating Margin % | -255.66 | |||||
Net Margin % | -296.15 | |||||
FCF Margin % | -116.63 | |||||
ROE % | -17.72 | |||||
ROA % | -13.47 | |||||
ROIC % | -12.07 | |||||
ROC (Joel Greenblatt) % | -112.37 | |||||
ROCE % | -17.38 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 18.11 | |||||
PS Ratio | 25.07 | |||||
PB Ratio | 1.73 | |||||
Price-to-Tangible-Book | 1.75 | |||||
EV-to-EBIT | -9.03 | |||||
EV-to-EBITDA | -9.28 | |||||
EV-to-Revenue | 26.82 | |||||
EV-to-FCF | -23 | |||||
Price-to-Projected-FCF | 0.63 | |||||
Price-to-Median-PS-Value | 4.56 | |||||
Price-to-Net-Current-Asset-Value | 3.12 | |||||
Earnings Yield (Greenblatt) % | -11.07 | |||||
FCF Yield % | -4.38 | |||||
Forward Rate of Return (Yacktman) % | 39.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Inno-Gene SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | 0.415 | ||
EPS (TTM) (zł) | -0.212 | ||
Beta | -1.11 | ||
Volatility % | 53.34 | ||
14-Day RSI | 48.33 | ||
14-Day ATR (zł) | 0.006815 | ||
20-Day SMA (zł) | 1.78 | ||
12-1 Month Momentum % | -64.68 | ||
52-Week Range (zł) | 1.65 - 5.04 | ||
Shares Outstanding (Mil) | 6.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Inno-Gene SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Inno-Gene SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Inno-Gene SA Frequently Asked Questions
What is Inno-Gene SA(WAR:IGN)'s stock price today?
When is next earnings date of Inno-Gene SA(WAR:IGN)?
Does Inno-Gene SA(WAR:IGN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |